Retrieve available abstracts of 197 articles: HTML format
Single Articles
July 2025
WYEN C, Sabranski M, Jonsson-Oldenbuttel C, Bogner J, et al Effectiveness of switching to doravirine-based antiretroviral therapy: A
real-world study in Germany.
HIV Med. 2025 Jul 4. doi: 10.1111/hiv.70061. PubMedAbstract available
BASIIMA J, Ssempijja V, Ndyanabo A, Bua GM, et al Retention outcomes during same-day antiretroviral therapy initiation in health
facilities and outreach settings of Rakai, Uganda, 2016-2021.
HIV Med. 2025 Jul 4. doi: 10.1111/hiv.70064. PubMedAbstract available
MENDES DE LEON KF, Moody K, Nellen JF, van Vugt M, et al Mode of administration matters: Willingness of people with HIV to switch to
future long-acting treatments, and health care professionals' intention to
discuss these options.
HIV Med. 2025 Jul 2. doi: 10.1111/hiv.70066. PubMedAbstract available
VINAY D, Jayaweera I, Bowman M, Wijeratne DTD, et al Patient-reported outcomes in clinical trials assessing the effectiveness of
cabotegravir + rilpivirine long-acting injections as antiretroviral therapy: A
systematic review.
HIV Med. 2025 Jul 2. doi: 10.1111/hiv.70058. PubMedAbstract available
RAMADAN HK, Salah AE, Mohamed ZR, Ayoub A, et al False-positive reactivity of fourth-generation HIV enzyme immunoassay caused by
COVID-19 and other infections.
HIV Med. 2025 Jul 1. doi: 10.1111/hiv.70069. PubMedAbstract available
MAZZITELLI M, Leoni D, Campagnolo E, Cozzolino C, et al Anal cancer screening in a cohort of women with HIV: Uptake and outcomes from a
prospective study in Northern Italy.
HIV Med. 2025 Jul 1. doi: 10.1111/hiv.70068. PubMedAbstract available
June 2025
MAZZITELLI M, Trunfio M, Dube K, Lopez AM, et al Measuring HIV knowledge and attitudes in the health care setting: Italian results
from an ECDC/EACS survey.
HIV Med. 2025 Jun 26. doi: 10.1111/hiv.70067. PubMedAbstract available
GHOSN J, Chow J, Gandhi M, Gorgolas M, et al Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as
initial treatment in people with human immunodeficiency virus-1 (HIV-1): A
systematic literature review of clinical and patient-reported outcomes.
HIV Med. 2025 Jun 26. doi: 10.1111/hiv.70065. PubMedAbstract available
GHAZALI MI, Zaki RA, Danaee M Late diagnosis of human immunodeficiency virus (HIV) and its associated factors
in Asian countries: A systematic review.
HIV Med. 2025 Jun 25. doi: 10.1111/hiv.70046. PubMedAbstract available
REZENE F, Amoyaw B, Rodrigues M, Ofori S, et al Gender equality in leadership of HIV care cascade clinical trials: A
methodological study.
HIV Med. 2025 Jun 20. doi: 10.1111/hiv.70062. PubMedAbstract available
KAYA A, Benke D, Swan T, Breitschwerdt S, et al Use of dual antiretroviral therapy in individuals with different serological
patterns for hepatitis B: What are the risks? What are the clinical implications?
HIV Med. 2025 Jun 16. doi: 10.1111/hiv.70063. PubMed
RING K, Elias A, Devonald M, Smuk M, et al Long-acting injectable cabotegravir and rilpivirine in observational cohort
studies: A systematic review on virological failure, resistance and
re-suppression outcomes in virally suppressed individuals living with HIV.
HIV Med. 2025 Jun 13. doi: 10.1111/hiv.70057. PubMedAbstract available
NILSSON J, Elvstam O, Sorstedt E, Wagner P, et al Factors mediating and associated with immunological response in women living with
HIV in Sweden: A nationwide register-based study.
HIV Med. 2025 Jun 12. doi: 10.1111/hiv.70059. PubMedAbstract available
DEBROY P, Pike F, Gawrieh S, Corey KE, et al Circulating fibroblast growth factor 21 and growth differentiation factor 15 are
associated with severity of hepatic steatosis in people with HIV.
HIV Med. 2025 Jun 11. doi: 10.1111/hiv.70060. PubMedAbstract available
OKHAI H, Baskaran A, Bukasa L, Peters H, et al Changes in characteristics and HIV-clinical outcomes of pregnant people living
with HIV in the UK.
HIV Med. 2025 Jun 10. doi: 10.1111/hiv.70056. PubMedAbstract available
BALLIF M, Correia da Silva Saude M, Haerry D, Stoeckle M, et al Willingness to participate in clinical trials and expectations towards
antiretroviral therapy among heavily treatment-experienced people living with
HIV: A feasibility survey.
HIV Med. 2025 Jun 8. doi: 10.1111/hiv.70053. PubMedAbstract available
VACCARI LC, Ming DK, Hazell J, Hunter A, et al Causes of death in people living with HIV from a North London cohort between 2006
and 2023: A descriptive analysis.
HIV Med. 2025 Jun 4. doi: 10.1111/hiv.70054. PubMedAbstract available
CHIU SC, Wei LC Enhancing sexually transmitted and blood-borne infection prevention in
opioid-agonist therapy programmes: Lessons from a canadian pragmatic trial and
implications for Taiwan.
HIV Med. 2025 Jun 2. doi: 10.1111/hiv.70055. PubMed
May 2025
DOUTRE M, Godin MP, Dmitriev I, Pena-Gralle AP, et al Free antiretrovirals as a key tool against the HIV pandemic: A systematic review.
HIV Med. 2025 May 28. doi: 10.1111/hiv.70051. PubMedAbstract available
RASHID I, Unger NR, Willis C, Dhippayom T, et al Comparison of treatment-emergent resistance-associated mutations and
discontinuation due to adverse events among integrase strand transfer
inhibitor-based single-tablet regimens and cabotegravir + rilpivirine for the
treatment of virologically suppres
HIV Med. 2025 May 27. doi: 10.1111/hiv.70050. PubMedAbstract available
SAMANTHA PC, Eduardo PA, Adrian CO The silent crisis: Vertical HIV transmission and the struggle for antiretroviral
access.
HIV Med. 2025 May 26. doi: 10.1111/hiv.70052. PubMedAbstract available
KOKORELIAS KM, Valentine D, Eaton AD, Dove E, et al "They didn't think we'd live this long": A qualitative exploration of older
adults living with HIV perspectives on geriatric care in Ontario.
HIV Med. 2025 May 22. doi: 10.1111/hiv.70047. PubMedAbstract available
CARTIER A, Milinkovic A, Goodall L, Mora-Peris B, et al HIV seroconversions and genotypic viral resistance profiles in the PrEP impact
trial.
HIV Med. 2025 May 21. doi: 10.1111/hiv.70045. PubMedAbstract available
DIRAJLAL-FARGO S, Nyathi M, Sun S, Bonner LB, et al Metabolic syndrome and Pathobiological Determination of Atherosclerosis in Youth
risk score in adolescents with and without perinatally acquired HIV in the Cape
Town Adolescent and Antiretroviral Cohort (CTAAC)-Heart study.
HIV Med. 2025 May 21. doi: 10.1111/hiv.70049. PubMedAbstract available
FREER GB, Cooper J, Nirantharakumar K, Thomas GN, et al Trends in prevalence of anaemia among people living with HIV in the UK: 20
cross-sectional analyses using population-based electronic primary healthcare
records.
HIV Med. 2025 May 21. doi: 10.1111/hiv.70044. PubMedAbstract available
MENDEZ-LOPEZ A, Burns F, Sullivan A, Deogan C, et al Knowledge about biomedical HIV prevention among healthcare workers: A
cross-sectional study in Europe and Central Asia.
HIV Med. 2025 May 19. doi: 10.1111/hiv.70048. PubMedAbstract available
VAN BECKHOVEN D, Serrien B, Demeester R, Van Praet J, et al Dual cross-sectional and longitudinal perspective on the continuum of HIV care to
disentangle natural epidemic evolution from real progress, Belgium 2014-2022.
HIV Med. 2025 May 12. doi: 10.1111/hiv.70027. PubMedAbstract available
SCHULZ-MEDINA SE, Tapia-Trejo D, Matias-Florentino M, Lopez-Sanchez DM, et al HIV molecular network in Mexico City (2021-2022): Understanding transmission
dynamics through the role of newly diagnosed cases.
HIV Med. 2025 May 7. doi: 10.1111/hiv.70029. PubMedAbstract available
JONES HT, Lynch L, Barber TJ, Rattue M, et al What services, interventions and support are available for People with HIV in
England to manage their overall health and wellbeing? A scoping review.
HIV Med. 2025 May 7. doi: 10.1111/hiv.70041. PubMedAbstract available
COTA MEDEIROS F, Mendez-Lopez A, Correia de Abreu R, Sarmento E Castro R, et al Knowledge and HIV-related stigma among Portuguese healthcare professionals: A
cross-sectional analysis.
HIV Med. 2025 May 7. doi: 10.1111/hiv.70039. PubMedAbstract available
ATALAY S, Mert K, Caglayan D, Sonmez U, et al Factors affecting treatment adherence in people with HIV - A single-Centre
Descriptive Study from Turkey.
HIV Med. 2025 May 6. doi: 10.1111/hiv.70042. PubMedAbstract available
POVSHEDNA T, Swann SA, Silva MAP, Tognazzini S, et al Self-reported HIV viral load is reliable and not affected by adverse lived
experiences of women living with HIV in British Columbia.
HIV Med. 2025 May 6. doi: 10.1111/hiv.70035. PubMedAbstract available
MENDES-FERREIRA AAC, Beber AMB, da Silveira LN, Guarabyra ASD, et al Assessment of compliance with recommendations for HIV perinatal transmission
prevention, timely diagnosis and early treatment of children living with HIV in
Brazil.
HIV Med. 2025 May 6. doi: 10.1111/hiv.70038. PubMedAbstract available
LAPO-TALLEDO GJ, Zamora Cevallos AL, Arteaga Reyes CR, Sanchez Redroban JD, et al HIV disease hospitalizations and factors associated with in-hospital mortality in
Ecuador: A nationwide analysis from 2015 to 2023.
HIV Med. 2025 May 4. doi: 10.1111/hiv.70040. PubMedAbstract available
MOKADDAM M, Kronfli N, Sheehan NL, Gonzalez Reyes A, et al Antiretroviral therapy use, self-reported adherence, and viral suppression among
women living with HIV in Canada.
HIV Med. 2025 May 2. doi: 10.1111/hiv.70034. PubMedAbstract available
NAKAGAWA F, Palich R, Kall M, Sewell J, et al Impact of COVID-19 and factors associated with long COVID and COVID-19 vaccine
uptake in people with HIV in the United Kingdom: Results from Positive Voices
2022.
HIV Med. 2025 May 1. doi: 10.1111/hiv.70026. PubMedAbstract available
MAZZITELLI M, Petrara MR, Cozzolino C, Sasset L, et al Immune profiles and HIV reservoir in people switching to long-acting
cabotegravir/rilpivirine: Findings from a real-life prospective study.
HIV Med. 2025 May 1. doi: 10.1111/hiv.70030. PubMedAbstract available
April 2025
DE VITO A, Tavelli A, Cozzi-Lepri A, Giacomelli A, et al Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir
alafenamide following dual regimen therapy in people with HIV: Insights from the
Icona cohort.
HIV Med. 2025 Apr 28. doi: 10.1111/hiv.70037. PubMedAbstract available
QUISIAS J, Gill MJ, Coburn SB, Krentz HB, et al Cytomegalovirus serostatus among people with HIV, characterizing the prevalence,
risk factors, and association with immune recovery.
HIV Med. 2025 Apr 28. doi: 10.1111/hiv.70036. PubMedAbstract available
IRELAND AT, Ward J, Dolby H, Lawrence C, et al Using an automated decision support tool to improve HIV prescribing: A
feasibility study.
HIV Med. 2025 Apr 24. doi: 10.1111/hiv.70028. PubMedAbstract available
XIAO M, Shi Y, Lao Y, Ma Y, et al HCV incidence in people with HIV in southwest China: A retrospective cohort study
(2004-2023).
HIV Med. 2025 Apr 19. doi: 10.1111/hiv.70033. PubMedAbstract available
Correction to "Perception of medical care among women living with HIV aged
40 years or older-a European-wide survey".
HIV Med. 2025 Apr 14. doi: 10.1111/hiv.70032. PubMed
ADMASSU Z, Logie CH, Vahedi L, Underhill A, et al Longitudinal associations between social determinants of health and well-being
among women living with HIV in Canada: A latent class analysis.
HIV Med. 2025 Apr 14. doi: 10.1111/hiv.70031. PubMedAbstract available
BARDA B, Barilaro G, Bellini P, Turicchi G, et al Efficacy of long-acting cabotegravir plus rilpivirine in viraemic people living
with HIV: A systematic review and meta-analysis.
HIV Med. 2025 Apr 9. doi: 10.1111/hiv.70025. PubMedAbstract available
ZUBAIR A, Ahmad H, Arif MM, Ali M, et al mRNA vaccines against HIV: Hopes and challenges.
HIV Med. 2025 Apr 7. doi: 10.1111/hiv.70024. PubMedAbstract available
ZHAO J, Gao M, Zhao D, Tian W, et al Prevalence of late HIV diagnosis and its impact on mortality: A comprehensive
systematic review and meta-analysis.
HIV Med. 2025 Apr 3. doi: 10.1111/hiv.70023. PubMedAbstract available
CHACHU KH, Maboe KA Strategies for strengthening same-day ART initiation, tracing people living with
HIV lost to follow-up and viral load monitoring mechanisms in Ethiopia.
HIV Med. 2025 Apr 3. doi: 10.1111/hiv.70022. PubMedAbstract available
BHIVA Spring Conference 2025, 23 April - 25 April 2025, Brighton, UK.
HIV Med. 2025;26 Suppl 2:17-137. PubMed
BHIVA Spring Conference 2025, 23 April - 25 April 2025, Brighton, UK.
HIV Med. 2025;26 Suppl 2:3-16. PubMed
March 2025
BARTOVSKA Z, Massmann R, Jilich D, Groh T, et al Late diagnosis of HIV among Ukrainian refugees in the Czech Republic: A
retrospective, observational study.
HIV Med. 2025 Mar 29. doi: 10.1111/hiv.70021. PubMedAbstract available
AKSAK-WAS B, Skonieczna-Zydecka K, Parczewski M, Hrynkiewicz R, et al Rethinking HIV treatment: How non-integrase strand regimens may hold the key to
better immune health.
HIV Med. 2025 Mar 28. doi: 10.1111/hiv.70020. PubMedAbstract available
MOSHI LS, Okuma J, Luoga E, Kalinjuma AV, et al Trends of severe HIV disease and mortality among children in rural Tanzania.
HIV Med. 2025 Mar 25. doi: 10.1111/hiv.70015. PubMedAbstract available
SAUMOY M, Fernandez A, Tiraboschi J, Penafiel J, et al Biomarkers of inflammation and coagulation predict non-AIDS-defining events in a
prospective cohort of virologically suppressed people living with HIV.
HIV Med. 2025 Mar 25. doi: 10.1111/hiv.70017. PubMedAbstract available
VASELLI NM, Salaveria K, Winearls J, Garnham K, et al Pneumocystis jirovecii pneumonia-Immune reconstitution inflammatory syndrome: A
review of published cases.
HIV Med. 2025 Mar 24. doi: 10.1111/hiv.70016. PubMedAbstract available
MARTORELL C, Ramgopal M, Hagins D, Osiyemi O, et al Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black
and Hispanic/Latine adults with HIV-1 initiating first-line therapy: 5-year
follow-up from two phase III studies.
HIV Med. 2025 Mar 21. doi: 10.1111/hiv.70018. PubMedAbstract available
PINCUS KJ, Faridi N, Ryscavage PA, Seung H, et al Assessing weight change in adolescents and young adults with perinatally acquired
HIV and integrase inhibitor use.
HIV Med. 2025 Mar 20. doi: 10.1111/hiv.70019. PubMedAbstract available
HERNANDEZ-TRUJILLO PN, Lopez-Baron CA, Arevalo-Pinzon G, Trujillo-Guiza ML, et al Taxonomic and functional profile of the anorectal microbiota in HIV-positive and
HIV-negative men who have sex with men, using a metagenomic approach.
HIV Med. 2025 Mar 18. doi: 10.1111/hiv.70014. PubMedAbstract available
CHAWLA S, Kaida A, Brouillette MJ, Kleiner B, et al Impact of mental health service use on the HIV care cascade among women.
HIV Med. 2025 Mar 4. doi: 10.1111/hiv.70008. PubMedAbstract available
SURIYARACHCHI DDC, Katuwavila NP Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for
HIV/AIDS treatment.
HIV Med. 2025 Mar 4. doi: 10.1111/hiv.13770. PubMedAbstract available
HE X, Zheng W, Wang X, Jiang Y, et al Trend of HIV/AIDS disease burden in China from 1990 to 2021: An age-period-cohort
model analysis.
HIV Med. 2025 Mar 4. doi: 10.1111/hiv.70009. PubMedAbstract available
DOAK 2025 / 12th German-Austrian AIDS Congress, 20-22 March 2025, Hofburg Vienna.
HIV Med. 2025;26 Suppl 1:3-82. PubMed
February 2025
GIFFORD AJ, Jaspal R, Jones BA, McDermott DT, et al Predicting PrEP acceptability and self-efficacy among men who have sex with men
in the UK: The roles of identity resilience, science mistrust, and stigma.
HIV Med. 2025 Feb 27. doi: 10.1111/hiv.13768. PubMedAbstract available
HENDERSON M, Lyons D, Beddows S, Cowen M, et al High-risk human papillomavirus prevalence and serostatus in a cohort of cisgender
women and people with a cervix living with perinatally acquired HIV.
HIV Med. 2025 Feb 25. doi: 10.1111/hiv.70001. PubMedAbstract available
BEGUELIN C, Surial B, Hofmann E, Begre L, et al Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy
in persons with HIV/hepatitis B virus coinfection.
HIV Med. 2025 Feb 25. doi: 10.1111/hiv.13766. PubMedAbstract available
BLANCH J, Martinez E, Mena A, Duenas C, et al Impact of training healthcare professionals in the detection and management of
neuropsychiatric comorbidities in people with HIV: The CONECTAR project in Spain.
HIV Med. 2025 Feb 24. doi: 10.1111/hiv.70002. PubMedAbstract available
ELKHEIR N, Dominic C, Price A, Carter J, et al HIV in Latin American migrants in the UK: A neglected population in the 95-95-95
targets.
HIV Med. 2025 Feb 24. doi: 10.1111/hiv.70007. PubMedAbstract available
YU S, MacGibbon J, Bavinton B, Smith AKJ, et al Associations between country of birth, migration status and engagement in HIV
care among gay and bisexual men living with HIV in Australia, 2019-2022.
HIV Med. 2025 Feb 19. doi: 10.1111/hiv.13769. PubMedAbstract available
AKASHANAND, Khatib MN, Serhan HA, Jena D, et al Spatial and temporal trends in HIV/AIDS burden among South Asian countries from
1990 to 2021: A systematic examination of the Global Burden of Disease study
2021.
HIV Med. 2025 Feb 19. doi: 10.1111/hiv.70003. PubMedAbstract available
MEDINA N, Alastruey-Izquierdo A, Bonilla O, Mercado D, et al Patients re-engaging with HIV care in Guatemala: Prioritizing CD4 counting and
screening for histoplasmosis and tuberculosis.
HIV Med. 2025 Feb 17. doi: 10.1111/hiv.70000. PubMedAbstract available
SADIQ E, Woodiwiss A, Tade G, Nel J, et al The role of atherosclerosis in HIV-associated vasculopathy in young South African
stroke patients.
HIV Med. 2025 Feb 13. doi: 10.1111/hiv.13764. PubMedAbstract available
NAZARENKO N, Chen YY, Borkowski P, Biavati L, et al Weight and mortality in people living with HIV and heart failure: Obesity paradox
in the era of glucagon-like peptide 1 (GLP-1) receptor agonists and
sodium-glucose cotransporter-2 (SGLT-2) inhibitors.
HIV Med. 2025 Feb 13. doi: 10.1111/hiv.13760. PubMedAbstract available
KUMAR S, Mehta R, Sah R, Verma A, et al Commentary on 'Exploring the cascade of mental healthcare among people with HIV
experiencing depressive symptoms in the UK and Ireland: The POPPY study'.
HIV Med. 2025 Feb 5. doi: 10.1111/hiv.13767. PubMed
YANG Q, Zhou J, Lan G, Qin Q, et al Factors influencing the quality of life and social skills of children living with
HIV: A case-control study.
HIV Med. 2025 Feb 5. doi: 10.1111/hiv.13758. PubMedAbstract available
SALVO PF, Ciccullo A, Visconti E, Lombardi F, et al Impact of HBV serological status on HIV virological efficacy of two-drug
antiretroviral regimens: A retrospective observational study on virologically
suppressed people with HIV switching to lamivudine/dolutegravir.
HIV Med. 2025 Feb 5. doi: 10.1111/hiv.13765. PubMedAbstract available
January 2025
PINAR SS, Manak M, Saravanan S, Imami N, et al Point-of-care nucleic acid testing - a step forward in controlling the HIV
epidemic: A review.
HIV Med. 2025 Jan 25. doi: 10.1111/hiv.13757. PubMedAbstract available
ODONGPINY EAL, Nicol M, Katana E, Owori J, et al A programmatic assessment of dolutegravir adverse events and discontinuations in
Uganda.
HIV Med. 2025 Jan 24. doi: 10.1111/hiv.13761. PubMedAbstract available
IZQUIERDO R, Suarez-Garcia I, Marco-Sanchez C, Perez-Latorre L, et al Health-related quality of life in people with HIV from the multicentre CoRIS
cohort in Spain: Associated factors and short-term changes over time.
HIV Med. 2025 Jan 21. doi: 10.1111/hiv.13762. PubMedAbstract available
MKHIZE N, Garrido J, Cole-Haley S, Diallo DD, et al Breaking down global barriers: A multinational and multi-community approach to
combat stigma and enhance mental wellbeing in people with HIV.
HIV Med. 2025 Jan 16. doi: 10.1111/hiv.13763. PubMedAbstract available
MCGARRITY MW, MacPherson P, Li A, Naccarato M, et al Intracellular tenofovir-diphosphate concentrations in HIV pre-exposure
prophylaxis users who underwent bariatric surgery.
HIV Med. 2025 Jan 15. doi: 10.1111/hiv.13759. PubMedAbstract available
WALKER SH, Grierson J, Sullivan A, Alagaratnam J, et al The effects of the COVID-19 pandemic on people living with HIV.
HIV Med. 2025 Jan 6. doi: 10.1111/hiv.13754. PubMedAbstract available
HU T, Yang S, Yu J, Yang Z, et al Transitions in treatment: A systematic review and meta-aggregation of preferences
and barriers in switching from oral to long-acting injectable antiretroviral
therapy among people living with HIV and stakeholders.
HIV Med. 2025 Jan 2. doi: 10.1111/hiv.13756. PubMedAbstract available
December 2024
VARMA A, Singh MP, Sah S, Verma A, et al Commentary on 'DORA: 48-week weight and metabolic changes in black women with
HIV, in a phase IIIb switch study from dolutegravir- or efavirenz- to
doravirine-based first-line antiretroviral therapy'.
HIV Med. 2024 Dec 26. doi: 10.1111/hiv.13755. PubMed
SANDULESCU O, Moseholm E Editorial comment on: "It's like it's the old boys Club: The age-related
experiences of diverse older women living with HIV: A scoping review and
consultative exercise".
HIV Med. 2024 Dec 22. doi: 10.1111/hiv.13750. PubMed
OKHAI H, Winston A, Post F, Boffito M, et al Exploring the cascade of mental healthcare among people with HIV experiencing
depressive symptoms in the UK and Ireland: The POPPY study.
HIV Med. 2024 Dec 19. doi: 10.1111/hiv.13753. PubMedAbstract available
MIRON VD, Sabin CA, Sandulescu O, Lourida G, et al Perception of medical care among women living with HIV aged 40 years or older-A
European-wide survey.
HIV Med. 2024 Dec 15. doi: 10.1111/hiv.13749. PubMedAbstract available
KOKORELIAS KM, Su E, Brown P, McKinlay S, et al "It's like it's the old boys club"-the age-related experiences of diverse older
women living with HIV: A scoping review and consultative exercise.
HIV Med. 2024 Dec 12. doi: 10.1111/hiv.13751. PubMedAbstract available
BARRE T, Ramier C, Ory K, Sogni P, et al Transient CD4 cell recovery after hepatitis C virus cure in HIV/hepatitis C virus
coinfected patients (ANRS CO13 HEPAVIH cohort).
HIV Med. 2024 Dec 11. doi: 10.1111/hiv.13752. PubMed
ALFORD K, Sidat S, Bristowe K, Cicconi P, et al Lenacapavir: Patient and healthcare provider perceptions and the potential role
for a twice-yearly injectable HIV treatment.
HIV Med. 2024 Dec 10. doi: 10.1111/hiv.13748. PubMedAbstract available
FALCI DR, Pasqualotto AC, Vieceli T, Sued O, et al Performance of urine Xpert MTB/RIF ultra in a tuberculosis screening strategy in
hospitalized patients with advanced HIV disease: Results from an implementation
initiative in Brazil.
HIV Med. 2024 Dec 10. doi: 10.1111/hiv.13746. PubMedAbstract available
SZETELA B, Bozejko M, Szymczak A, Giniewicz K, et al Rapid HIV pre-exposure prophylaxis (PrEP) initiation is safe and feasible:
Experience from Wroclaw All Saints cohort in Poland 2017-2021.
HIV Med. 2024 Dec 5. doi: 10.1111/hiv.13747. PubMedAbstract available
D'ARMINIO MONFORTE A, Tavelli A, Quiros-Roldan E, Fabbiani M, et al Predictors for choosing doravirine-based versus INSTI-based regimen in ART-naive
and ART-experienced people with HIV in real-world setting: Data from the Icona
cohort.
HIV Med. 2024 Dec 2. doi: 10.1111/hiv.13740. PubMedAbstract available
NELSON M, Bracchi M, Hunter E, Ong E, et al British HIV Association guidelines on the management of opportunistic infection
in people living with HIV: The clinical management of non-tuberculous
mycobacteria 2024.
HIV Med. 2024;25 Suppl 4:3-25. PubMed
November 2024
OJUKWU E, Pashaei A, Maia JC, Omobhude OF, et al Impact of the COVID-19 pandemic on the HIV care continuum and associated factors
in middle-income countries: A mixed-methods systematic review.
HIV Med. 2024 Nov 28. doi: 10.1111/hiv.13739. PubMedAbstract available
JONES HT, Barber TJ A qualitative study of perspectives, experiences and priority outcomes for people
living with HIV and frailty: Editorial comment on: "We are fragile, but we are
strong": Navigating Frailty and HIV in Aging Populations: Perspectives on
Language, Stigma
HIV Med. 2024 Nov 28. doi: 10.1111/hiv.13736. PubMed
YU X, Kuo YF, Dike AA, Efejuku T, et al Trends and disparities in antiretroviral therapy prescription rates among US
Medicare beneficiaries with HIV.
HIV Med. 2024 Nov 25. doi: 10.1111/hiv.13745. PubMedAbstract available
BARBOSU CM, Avirvarei C, Manciuc C, Dye T, et al Stigma-associated attitudes and practices among Romanian clinical providers.
HIV Med. 2024 Nov 25. doi: 10.1111/hiv.13742. PubMedAbstract available
BLANCO JR, Gonzalez-Baeza A, Martinez-Vicente A, Albendin-Iglesias H, et al Loneliness and social isolation in people with HIV aged >/=50 years. The No One
Alone (NOA)-GeSIDA study conducted by the GeSIDA 12021 study group.
HIV Med. 2024 Nov 22. doi: 10.1111/hiv.13743. PubMedAbstract available
PENNER J, Ombajo LA, Nkuranga J, Otieno E, et al High prevalence of osteoporosis among virally suppressed older people (>/=60 years)
living with HIV.
HIV Med. 2024 Nov 21. doi: 10.1111/hiv.13741. PubMedAbstract available
BAKEWELL N, Kanitkar T, Dissanayake O, Symonds M, et al Comparing short-term mortality between people with and without HIV admitted to
the intensive care unit: A single-centre matched cohort study (2000-2019).
HIV Med. 2024 Nov 20. doi: 10.1111/hiv.13737. PubMedAbstract available
METCALFE R, Fraser R, Trayner KMA, Glancy M, et al Rising mortality among people who inject drugs living with HIV in Scotland, UK: A
20-year retrospective cohort study.
HIV Med. 2024 Nov 18. doi: 10.1111/hiv.13733. PubMedAbstract available
KENIYOPOULLOS R, Khawaja AA, Boffito M, Emerson M, et al In vitro and patient studies with platelets to explore off-target cardiovascular
effects of integrase inhibitors.
HIV Med. 2024 Nov 15. doi: 10.1111/hiv.13738. PubMedAbstract available
BLAKEY EG, Fairhead CEL, Rodger AJ, Burns FM, et al Clinical staff attitudes towards opt-out consent for blood-borne virus screening
in emergency departments in England.
HIV Med. 2024 Nov 13. doi: 10.1111/hiv.13735. PubMedAbstract available
RODKJAER LO, Storgaard M, Schougaard LMV Implementation of patient-reported outcomes for people living with HIV: Insights
from patients and healthcare providers in a Danish outpatient clinic.
HIV Med. 2024 Nov 13. doi: 10.1111/hiv.13734. PubMedAbstract available
SEMPERE A, Gonzalez-Rioja X, Martinez E AI in medicine: No longer the future, but the present.
HIV Med. 2024 Nov 11. doi: 10.1111/hiv.13732. PubMed
LAGUNO M, de Lazzari E, Berrocal L, Inciarte A, et al Burden of liver steatosis and liver fibrosis in a large cohort of people living
with HIV.
HIV Med. 2024 Nov 7. doi: 10.1111/hiv.13730. PubMedAbstract available
ABGRALL S, Selinger-Leneman H, Lanoy E, Becker A, et al Viral rebound on antiretroviral therapy in France according to region of origin,
sex, and HIV acquisition group. Results from the French Hospital Database on HIV
(ANRS CO4-FHDH).
HIV Med. 2024 Nov 4. doi: 10.1111/hiv.13729. PubMedAbstract available
October 2024
STEPHAN C, Spinner CD, Rieke A, Christensen S, et al Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir
alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month
results from the prospective German TAFNES cohort study.
HIV Med. 2024 Oct 30. doi: 10.1111/hiv.13728. PubMedAbstract available
WATERS L, Martinez E Cardiovascular prevention: Statins and beyond-A message from the editors of the
special issue of HIV medicine.
HIV Med. 2024 Oct 29. doi: 10.1111/hiv.13731. PubMed
HICKS WL, Khalil S, Burke FW, Ho MQ, et al Comparison of risk factors and mortality in veterans with HIV and those without
HIV suffering first major acute cardiovascular events.
HIV Med. 2024 Oct 27. doi: 10.1111/hiv.13724. PubMedAbstract available
IZQUIERDO R, Suarez-Garcia I, Gomez-Garcia T, Marco-Sanchez C, et al Should we measure quality of life among people with HIV? A multicentre survey of
physicians' opinions in Spain.
HIV Med. 2024 Oct 25. doi: 10.1111/hiv.13726. PubMedAbstract available
FERNANDES G, Chappell E, Goetghebuer T, Kahlert CR, et al HIV postnatal prophylaxis and infant feeding policies vary across Europe: results
of a Penta survey.
HIV Med. 2024 Oct 23. doi: 10.1111/hiv.13723. PubMedAbstract available
FONSECA F, Avelino-Silva VI, Odoke W, van den Hombergh J, et al Are people with HIV at advanced disease stages being left behind? A global
survey.
HIV Med. 2024 Oct 18. doi: 10.1111/hiv.13725. PubMedAbstract available
CLAIR-SULLIVAN NS, Vera JH, Maddocks M, Harding R, et al 'We are fragile, but we are strong': A qualitative study of perspectives,
experiences and priority outcomes for people living with HIV and frailty.
HIV Med. 2024 Oct 13. doi: 10.1111/hiv.13722. PubMedAbstract available
MA Y, Achiche S, Tu G, Vicente S, et al The first AI-based Chatbot to promote HIV self-management: A mixed methods
usability study.
HIV Med. 2024 Oct 10. doi: 10.1111/hiv.13720. PubMedAbstract available
ERON JJ, Ramgopal M, Osiyemi O, Mckellar M, et al Bictegravir/emtricitabine/tenofovir alafenamide in adults with HIV-1 and
end-stage kidney disease on chronic haemodialysis.
HIV Med. 2024 Oct 6. doi: 10.1111/hiv.13721. PubMedAbstract available
TRAYNER KMA, Palmateer NE, McAuley A, Yeung A, et al Examining trends in the incidence of HIV infection among people with a history of
drug use to inform an outbreak investigation and response: A retrospective cohort
study.
HIV Med. 2024 Oct 4. doi: 10.1111/hiv.13712. PubMedAbstract available
PLATTEAU T, Herrijgers C, Barvaux V, Vanden Berghe W, et al Chemsex and its impact on gay and bisexual men who have sex with men: Findings
from an online survey in Belgium.
HIV Med. 2024 Oct 3. doi: 10.1111/hiv.13717. PubMedAbstract available
September 2024
GUTIERREZ F "Editorial comment on: Increased incidence of diabetes in people living with HIV
treated with first-line integrase strand transfer inhibitors: A French
multicentre retrospective study".
HIV Med. 2024 Sep 27. doi: 10.1111/hiv.13719. PubMed
NIMKAR S, Kinikar A, Mave V, Khol V, et al Long-term risk of mortality and loss to follow-up in children and adolescents on
antiretroviral therapy in Asia.
HIV Med. 2024 Sep 26. doi: 10.1111/hiv.13718. PubMedAbstract available
MENDES-FERREIRA AAC, Veras NMC, Pinho REGG, Pascom AR, et al HIV drug resistance, viral suppression, and survival in children living with HIV
in Brazil.
HIV Med. 2024 Sep 25. doi: 10.1111/hiv.13714. PubMedAbstract available
NAZARETH J, Adebayo A, Fahad M, Karim H, et al Cardiovascular medication adherence testing in patients living with HIV: A
single-centre observational study.
HIV Med. 2024 Sep 24. doi: 10.1111/hiv.13715. PubMedAbstract available
MANYARA AM, Manyanga T, Burton A, Wilson H, et al Prevalence, factors and quality of life associated with frailty and pre-frailty
in middle-aged and older adults living with HIV in Zimbabwe: A cross-sectional
study.
HIV Med. 2024 Sep 20. doi: 10.1111/hiv.13716. PubMedAbstract available
FAROOQ HZ, Whitton L, Mwendera C, Divall P, et al Virtual care pathways for people living with HIV: A mixed-methods systematic
review.
HIV Med. 2024 Sep 17. doi: 10.1111/hiv.13701. PubMedAbstract available
WOODS J, Sokhela S, Akpomiemie G, Bosch B, et al DORA: 48-week weight and metabolic changes in Black women with HIV, in a phase
IIIb switch study from dolutegravir- or efavirenz- to doravirine-based first-line
antiretroviral therapy.
HIV Med. 2024 Sep 17. doi: 10.1111/hiv.13711. PubMedAbstract available
DAY S, Rae C, McOwan A, Wilkins R, et al Patient evaluation of Klick, a technology-enabled, nurse-delivered HIV outpatient
pathway.
HIV Med. 2024 Sep 15. doi: 10.1111/hiv.13710. PubMedAbstract available
Correction to "Severe haematologic toxicity is rare in high risk HIV-exposed
infants receiving combination neonatal prophylaxis".
HIV Med. 2024 Sep 11. doi: 10.1111/hiv.13713. PubMed
BARBER TJ, Clarke A, Fox A, Mackie NE, et al CROI 2024 BHIVA working group summary.
HIV Med. 2024 Sep 10. doi: 10.1111/hiv.13705. PubMedAbstract available
YANG X, Shi F, Zhang H, Giang WA, et al Long COVID among people with HIV: A systematic review and meta-analysis.
HIV Med. 2024 Sep 10. doi: 10.1111/hiv.13708. PubMedAbstract available
PINEIRO C, Policarpo S, Caldas C, Santos L, et al Real-world effectiveness and safety of switching to dolutegravir/lamivudine among
people living with HIV-1 aged over 50 years who are virologically suppressed.
HIV Med. 2024 Sep 6. doi: 10.1111/hiv.13699. PubMedAbstract available
PREVOTEAU DU CLARY F, Majerholc C, Zucman D, Livrozet JM, et al Evaluation of HIV antiretroviral treatment adherence in 2019 using anonymized
data from the French national health insurance claims data base: The COCOVIH
study.
HIV Med. 2024 Sep 5. doi: 10.1111/hiv.13690. PubMedAbstract available
MCCALL KL, Cabral DL, Coghlan JF, Concepcion AM, et al Therapeutic failure reported with HIV long-acting injectables: An analysis of the
FDA Adverse Event Reporting System from 2021 to 2024.
HIV Med. 2024 Sep 5. doi: 10.1111/hiv.13709. PubMedAbstract available
SHU Y, Zhang M, Li J, Deng X, et al Trajectories of CD4 T-cell count, CD8 T-cell count, and CD4/CD8 ratio in patients
with HIV and long-term virological suppression based on Yunnan HIV cohort.
HIV Med. 2024 Sep 2. doi: 10.1111/hiv.13707. PubMedAbstract available
August 2024
KO S, Dominguez-Dominguez L, Ottaway Z, Campbell L, et al Cardiovascular disease risk in people of African ancestry with HIV in the United
Kingdom.
HIV Med. 2024 Aug 29. doi: 10.1111/hiv.13706. PubMedAbstract available
URSENBACH A, Sireyjol A, Delpierre C, Duvivier C, et al Increased incidence of diabetes in people living with HIV treated with first-line
integrase strand transfer inhibitors: A French multicentre retrospective study.
HIV Med. 2024 Aug 28. doi: 10.1111/hiv.13698. PubMedAbstract available
LI N, Thomas L, Allan A, John B, et al Optimizing statin prescriptions for people living with HIV: Evidence for improved
communication and shared care between primary care and specialist HIV services.
HIV Med. 2024 Aug 26. doi: 10.1111/hiv.13704. PubMedAbstract available
HSU RK, Brunet L, Lackey PC, Pierone G Jr, et al Immunological and virological response to fostemsavir in routine US clinical
care: An OPERA cohort study.
HIV Med. 2024 Aug 25. doi: 10.1111/hiv.13700. PubMedAbstract available
GRINSPOON SK, Lu MT, Zanni MV, Diggs MR, et al What have we learned from the REPRIEVE trial and where do we go from here?
HIV Med. 2024 Aug 25. doi: 10.1111/hiv.13703. PubMed
VASHISHT S, Thakur N, Kant S, Rai S, et al Assessment of targeted intervention programme under the National AIDS Control
Program among men who have sex with men in India.
HIV Med. 2024 Aug 25. doi: 10.1111/hiv.13702. PubMedAbstract available
SWIFT E, Upton G, Fitzpatrick C, Roberts J, et al Impact of omission of routine blood monitoring of stable patients living with HIV
during the coronavirus pandemic.
HIV Med. 2024 Aug 18. doi: 10.1111/hiv.13696. PubMedAbstract available
CHAN CK, Huang SS, Wong KH, Leung CC, et al No increased risk of tuberculosis-related immune reconstitution inflammatory
syndrome with integrase inhibitor-based antiretroviral therapy in people with
HIV with profound immunosuppression.
HIV Med. 2024 Aug 12. doi: 10.1111/hiv.13695. PubMedAbstract available
WHITE TM, Fuster-RuizdeApodaca MJ, Iniesta C, Prats-Silvestre C, et al Network analysis to prioritize issues for intervention to improve the
health-related quality of life of people with HIV in Spain.
HIV Med. 2024 Aug 10. doi: 10.1111/hiv.13693. PubMedAbstract available
BEKELE A, Ahmed I, Tefera F, Yimam JA, et al Incidence and predictors of attrition from HIV treatment among adults living with
HIV in high-caseload facilities following implementation of universal test and
treat strategy in Ethiopia: A prospective cohort study.
HIV Med. 2024 Aug 6. doi: 10.1111/hiv.13691. PubMedAbstract available
SAH S, Verma A, Zahiruddin QS, Rustagi S, et al Commentary on 'Multicentre service evaluation of injectable cabotegravir and
rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI-net)'.
HIV Med. 2024 Aug 1. doi: 10.1111/hiv.13689. PubMed
KABLAWI D, Milic J, Thomas T, Fotsing Tadjo T, et al Metabolic dysfunction-associated steatohepatitis exhibits sex differences in
people with HIV.
HIV Med. 2024 Aug 1. doi: 10.1111/hiv.13697. PubMedAbstract available
July 2024
INESTROZA K, Hurtado V, Larson ME, Satish S, et al Characterizing heart failure and its subtypes in people living with HIV.
HIV Med. 2024 Jul 30. doi: 10.1111/hiv.13694. PubMedAbstract available
PIACENTINI D, Nicolini G, Bugana D, Piccolin G, et al Breastfeeding in women living with HIV in high-income countries: It's time to
act.
HIV Med. 2024 Jul 30. doi: 10.1111/hiv.13692. PubMed
SCOFIELD D, Frisch M, Andersson M, Storgaard M, et al Psychosocial and sexual health among men with and without HIV who have sex with
men: A cross-sectional nationwide study in Denmark.
HIV Med. 2024 Jul 18. doi: 10.1111/hiv.13688. PubMedAbstract available
RUIZ-BILBAO S, Videla S, Pascual E, Soler M, et al Functional and structural neuroretinal disorders in HIV Controllers. Prospective
cohort study.
HIV Med. 2024 Jul 9. doi: 10.1111/hiv.13685. PubMedAbstract available
ZAJDMAN-FAITELSON D, Cardenas-Hernandez ML, Guzman-Bucio S, Camiro-Zuniga A, et al Clinicopathological concordance of mucocutaneous manifestations in people living
with HIV: A cross-sectional study.
HIV Med. 2024 Jul 8. doi: 10.1111/hiv.13686. PubMedAbstract available
VERMA A, Pant M, Khatib MN, Singh MP, et al Commentary on 'Impact of hormonal therapy on HIV-1 immune markers in cis women
and gender minorities'.
HIV Med. 2024 Jul 2. doi: 10.1111/hiv.13687. PubMed
June 2024
SIMOES D, Raben D, Moran AB, Imaz A, et al The HepHIV 2023 Madrid conference: A call to action for political leadership in
reaching the sustainable development goals on earlier testing and linkage to care
for HIV, viral hepatitis, and sexually transmitted infections.
HIV Med. 2024 Jun 24. doi: 10.1111/hiv.13683. PubMedAbstract available
BARQUET-MUNOZ SA, Lopez-Morales RA, Stier EA, Mejorada-Pulido E, et al Prevalence of anal high-risk human papillomavirus (HR-HPV) types in people living
with HIV and a history of cancer.
HIV Med. 2024 Jun 20. doi: 10.1111/hiv.13684. PubMedAbstract available
BASOULIS D, Mastrogianni E, Eliadi I, Papadopoulou M, et al HCV-HIV co-infection in people who inject drugs: Barriers to treatment and cure
of HCV infection in the era of DAAs, a prospective study in Athens, Greece.
HIV Med. 2024 Jun 20. doi: 10.1111/hiv.13681. PubMedAbstract available
LAM JO, Hou CE, Alexeeff S, Levine T, et al Clinically recognized sleep disorders in people living with HIV.
HIV Med. 2024 Jun 18. doi: 10.1111/hiv.13682. PubMedAbstract available
RING K, Smuk M, Shongwe M, Okonta L, et al Multicentre service evaluation of injectable cabotegravir and rilpivirine
delivery and outcomes across 12 UK clinics (SHARE LAI-net).
HIV Med. 2024 Jun 10. doi: 10.1111/hiv.13679. PubMedAbstract available
HUTCHINSON J, Neesgard B, Kowalska J, Grabmeier-Pfistershammer K, et al Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive
analysis and comparison to men.
HIV Med. 2024 Jun 5. doi: 10.1111/hiv.13662. PubMedAbstract available
MALAGNINO V, Cozzi-Lepri A, Svicher V, Girardi E, et al Association between markers of hepatitis B virus infection and risk of
virological rebound in people with HIV receiving antiretroviral therapy.
HIV Med. 2024 Jun 4. doi: 10.1111/hiv.13680. PubMedAbstract available
PASIN C, Nunez DG, Kusejko K, Hachfeld A, et al Impact of hormonal therapy on HIV-1 immune markers in cis women and gender
minorities.
HIV Med. 2024 Jun 3. doi: 10.1111/hiv.13677. PubMedAbstract available
May 2024
CHROMY D, Urban N, Bauer WM, Kreuter A, et al Scars are frequently found as late sequelae in individuals affected by the 2022
mpox outbreak.
HIV Med. 2024 May 30. doi: 10.1111/hiv.13678. PubMedAbstract available
INGILIZ P, Lutz T, Schewe K, Baumgarten A, et al Recently acquired HCV infection in men who have sex with men in Germany in the
direct-acting antivirals era and during the COVID-19 pandemic.
HIV Med. 2024 May 29. doi: 10.1111/hiv.13651. PubMedAbstract available
SCHMIDT AJ, Weatherburn P, Wang H, Lutz T, et al Still trouble with bleeding: Risk factors for HCV transmission in men who have
sex with men and behavioural trajectories from 2019 to 2021.
HIV Med. 2024 May 27. doi: 10.1111/hiv.13657. PubMedAbstract available
SZCZEPANSKI A, Klesiewicz K, Ankiersztejn-Bartczak M, Drozdz K, et al Voluntary counselling and testing points (VCTs) in Poland as a complementary and
accessible alternative to public healthcare facilities: A comparative analysis of
epidemiological data from the VCTs and the National Institute of Public Health
NIH-Natio
HIV Med. 2024 May 21. doi: 10.1111/hiv.13658. PubMedAbstract available
YANG X, Zhang G, Kang W, Guo J, et al Related barriers to using HIV pre-exposure prophylaxis among MSM: A multicentre
cross-sectional survey.
HIV Med. 2024 May 21. doi: 10.1111/hiv.13663. PubMedAbstract available
KATLAMA C, Bisshop F, Bogner J, Perez Elias MJ, et al Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female
participants: week 48 data from the pooled TANGO and SALSA studies.
HIV Med. 2024 May 17. doi: 10.1111/hiv.13643. PubMedAbstract available
LOGIE CH, Sokolovic N, Casale A, Ndung'u M, et al Clinical HIV outcome trajectories associated with a history of child protective
service out-of-home care: Longitudinal cohort findings with women living with HIV
in Canada.
HIV Med. 2024 May 17. doi: 10.1111/hiv.13660. PubMedAbstract available
LUMBRERAS ARETA M, Migliorelli Falcone FE, Rudin C, Kahlert CR, et al Trends in preterm birth in women living with HIV in Switzerland over the last
three decades: A multicentric, prospective, cohort study.
HIV Med. 2024 May 16. doi: 10.1111/hiv.13652. PubMedAbstract available
BUSCA-ARENZANA C, Ortega-Gonzalez D, Diaz-Almiron M, Montes ML, et al Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV-1
treated with antiretroviral regimens that do not include tenofovir disoproxil
fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study.
HIV Med. 2024 May 15. doi: 10.1111/hiv.13659. PubMedAbstract available
NAKAMURA H, Yamamoto K Mpox in people with HIV: A narrative review.
HIV Med. 2024 May 15. doi: 10.1111/hiv.13661. PubMedAbstract available
BROWN L, Sargent P, Islam M, Downie C, et al Severe ocular Mpox in person living with advanced HIV treated with extended
course of tecovirimat.
HIV Med. 2024 May 9. doi: 10.1111/hiv.13656. PubMedAbstract available
FINLAYSON-TRICK E, Tam C, Wang L, Dawydiuk N, et al Access to care and impact on HIV treatment interruptions during the COVID-19
pandemic among people living with HIV in British Columbia.
HIV Med. 2024 May 9. doi: 10.1111/hiv.13654. PubMedAbstract available
MATACOTTA JJ, Tran D, Yoon S The prevalence of major depressive disorder in people with HIV: Results from the
All of Us Research Program.
HIV Med. 2024 May 7. doi: 10.1111/hiv.13653. PubMedAbstract available
OOSTERHOF P, de Zoete BGJA, Vanhommerig JW, Langebeek N, et al De-simplifying antiretroviral therapy from a single-tablet to a two-tablet
regimen: Acceptance, patient-reported outcomes, and cost savings in a multicentre
study.
HIV Med. 2024 May 7. doi: 10.1111/hiv.13655. PubMedAbstract available
DOCKRELL DH, Breen R, Collini P, Lipman MCI, et al British HIV Association guidelines on the management of opportunistic infection
in people living with HIV: The clinical management of pulmonary opportunistic
infections 2024.
HIV Med. 2024;25 Suppl 2:3-37. PubMed
GREIG J, Bamford A, Chadwick D, Darley A, et al British HIV Association guidelines on the management of opportunistic infection
in people living with HIV: Considerations in pregnancy 2024.
HIV Med. 2024;25 Suppl 3:3-19. PubMed
April 2024
LLIBRE JM, Garcia F, Blanco JL, Pelaez EP, et al Prevalence of people living with multidrug-resistant HIV and limited treatment
options in Spain.
HIV Med. 2024 Apr 30. doi: 10.1111/hiv.13650. PubMedAbstract available
DINESHA TR, Boobalan J, Kumar CV, Manikandan P, et al HIV-1 low-level viraemia predicts virological failure in first-line and
second-line ART-experienced individuals in India: A retrospective longitudinal
study.
HIV Med. 2024 Apr 25. doi: 10.1111/hiv.13641. PubMedAbstract available
BULLO M, Kierszenowicz T, Acosta MC, Rolon MJ, et al Telemedicine in HIV health care during the COVID-19 pandemic: An implementation
research study in Buenos Aires, Argentina.
HIV Med. 2024 Apr 24. doi: 10.1111/hiv.13646. PubMedAbstract available
JOHN M, Williams L, Nolan G, Bonnett M, et al Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of
the inJectable Antiretroviral therapy feasiBility Study (JABS).
HIV Med. 2024 Apr 21. doi: 10.1111/hiv.13647. PubMedAbstract available
DEMA E, Peters H, Gilleece Y, Thorne C, et al Residential and healthcare mobility during pregnancy among women living with HIV
in the UK, 2009-2019.
HIV Med. 2024 Apr 10. doi: 10.1111/hiv.13648. PubMedAbstract available
OZHMEGOVA E, Lebedev A, Antonova A, Kuznetsova A, et al Prevalence of HIV drug resistance at antiretroviral treatment failure across
regions of Russia.
HIV Med. 2024 Apr 7. doi: 10.1111/hiv.13642. PubMedAbstract available
CALZA L, Giglia M, Colangeli V, Bon I, et al Improvement in insulin sensitivity after switching from an integrase
inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in
people with significant weight gain.
HIV Med. 2024 Apr 3. doi: 10.1111/hiv.13644. PubMedAbstract available
BHIVA Spring Conference 2024, Birmingham, 29 April - 1 May 2024.
HIV Med. 2024;25 Suppl 1:21-111. PubMed
BHIVA Spring Conference 2024, Birmingham, 29 April - 1 May 2024.
HIV Med. 2024;25 Suppl 1:3-16. PubMed
BHIVA Spring Conference 2024, Birmingham, 29 April - 1 May 2024.
HIV Med. 2024;25 Suppl 1:17-20. PubMed
March 2024
LIU Y, Cheng Z, Xian Y, Liu X, et al Cascade analysis of awareness, willingness, uptake and adherence with regard to
PrEP among young men who have sex with men (YMSM) in China: A comparison between
students and non-students.
HIV Med. 2024 Mar 27. doi: 10.1111/hiv.13639. PubMedAbstract available
OTTAWAY Z, Campbell L, Fox J, Burns F, et al HIV outcomes during the COVID-19 pandemic in people of Black ethnicities living
with HIV in England.
HIV Med. 2024 Mar 26. doi: 10.1111/hiv.13640. PubMedAbstract available
SAWRY S, Ayalew K, Maimela G, Briggs-Hagen M, et al Assessment of weight gain in adult patients living with HIV receiving first-line
dolutegravir-based or efavirenz-based ART regimens in routine care clinics in
Tshwane district, South Africa: An observational study.
HIV Med. 2024 Mar 22. doi: 10.1111/hiv.13638. PubMedAbstract available
ZOU S, Chen Z, Tan Y, Tan M, et al Microbiomes detected by cerebrospinal fluid metagenomic next-generation
sequencing among patients with and without HIV with suspected central nervous
system infection.
HIV Med. 2024 Mar 21. doi: 10.1111/hiv.13634. PubMedAbstract available
SOCIAS ME, Cui Z, Le Foll B, Lei J, et al Sexually transmitted and blood-borne infection risk reduction with methadone and
buprenorphine/naloxone among people with prescription-type opioid use disorder:
Findings from a Canadian pragmatic randomized trial.
HIV Med. 2024 Mar 20. doi: 10.1111/hiv.13636. PubMedAbstract available
JACOBS TG, Okemo D, Ssebagereka A, Mwehonge K, et al Availability and stock-outs of paediatric antiretroviral treatment formulations
at health facilities in Kenya and Uganda.
HIV Med. 2024 Mar 18. doi: 10.1111/hiv.13635. PubMedAbstract available
DOU Y, Lu R, Su L, Lan K, et al Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using
a rifampicin-based regimen: A retrospective observational case series.
HIV Med. 2024 Mar 17. doi: 10.1111/hiv.13632. PubMedAbstract available
VIOLETTE LR, Thomas KK, Dorward J, Quame-Amaglo J, et al Early HIV viral suppression associated with subsequent 12-month treatment success
among people living with HIV in South Africa.
HIV Med. 2024 Mar 15. doi: 10.1111/hiv.13633. PubMedAbstract available
ZHAO J, Zhang L, Li L, Xie X, et al Growth of infants delivered by mothers with HIV in Guangxi, China: An 18-month
longitudinal follow-up study, 2015-2021.
HIV Med. 2024 Mar 13. doi: 10.1111/hiv.13624. PubMedAbstract available
TAHA AM, Elrosasy A, Mahmoud AM, Saed SAA, et al The effect of HIV and mpox co-infection on clinical outcomes: Systematic review
and meta-analysis.
HIV Med. 2024 Mar 5. doi: 10.1111/hiv.13622. PubMedAbstract available
PALICH R, Rodger AJ, Nicholls EJ, Wright T, et al Experiences with health care services and HIV testing after sexual assault in
cisgender gay, bisexual and other men who have sex with men and transgender
people.
HIV Med. 2024 Mar 3. doi: 10.1111/hiv.13629. PubMedAbstract available
FURSA O, Bannister W, Neesgaard B, Podlekareva D, et al SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people
with HIV across Europe in the multinational EuroSIDA cohort.
HIV Med. 2024 Mar 3. doi: 10.1111/hiv.13620. PubMedAbstract available
NOE S, Ivanova A, Johnsson-Oldenbuttel C, Schafer G, et al Immunological alterations with GLP-1 agonists in people living with HIV.
HIV Med. 2024 Mar 3. doi: 10.1111/hiv.13631. PubMed